Website Only Discount! Register now and save $100 off the Current In-Person Registration Fee! Please Mention Promo Code WEB at the time of Registration.
The 5th Annual Covered Entities’ 340B Summit has been rescheduled and will now take place from Wednesday, September 30 – Thursday, October 1. Given the current circumstances and the impact of COVID-19, as well as, information from the U.S. Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO), the health, safety, and well-being of our staff, speakers, attendees, sponsors, and partners is of utmost importance to us. Please continue to check back or click here to receive updates as they become available.
Demonstrate Compliance, Discuss Strategies for Successful Audits, and Evaluate the Financial Risks and Opportunities of Program Participation
The 5th Annual Covered Entities’ 340B Summit will explore the latest developments in the 340B space with regards to drug pricing transparency, HRSA 340B audits and other federal oversight activities, examine the impact of recent policy changes, consider trends in pharmacy contracting strategies and drug management practices, and strategies to maintain compliance and ensure program integrity.
- Discover how to ensure compliance and program integrity
- Develop audit preparation strategies
- Learn ways to resolve dispute findings between covered entities and drug manufacturers
- Minimize risks and maximize opportunities for financial savings